We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Credit Rating (CRISIL)
CARE B
Rates the company's debt-servicing ability — not the quality or value of its shares.
Rated: 8 Apr 2026
View Full ReportValuation
Financials (FY2025)
Source: CRISILInvestment Thesis
Alchemist Limited is under Corporate Insolvency Resolution Process (CIRP) with no active operations reported since 2019. Equity value is near zero. This is a distressed/insolvent entity with no investment merit for equity shareholders.
Pros
Cons
Business Segments
Healthcare & Pharmaceuticals
Hospitals and pharmaceutical manufacturing — formerly core segment.
Food Processing
Food processing operations including tea estates.
Real Estate & Infrastructure
Real estate development and infrastructure projects.
Revenue Model
Alchemist Limited generates revenue across multiple verticals: healthcare services through hospital operations, room revenues and F&B from hospitality assets, and project-based income from real estate development. The conglomerate model provides diversified revenue streams but requires significant capital allocation across unrelated sectors.
Detailed Analysis
Growth Plans
Potential asset monetization or strategic divestment of real estate or hospitality assets
Healthcare sector growth could improve hospital occupancy and revenues
Possible debt restructuring or management change to unlock value
India's hospitality recovery post-COVID could benefit hotel operations
Industry Tailwinds
Recent Developments
India's healthcare sector is undergoing consolidation with larger chains acquiring smaller hospital operators, creating both challenges and potential exit opportunities for diversified healthcare operators like Alchemist.
2024Comparable Companies
FORTIS · ~25000 Cr
Frequently Asked Questions
About Alchemist
Alchemist Limited is a New Delhi-based diversified conglomerate incorporated in 1988, with interests spanning healthcare, hospitality, fine dining, aviation, tea, steel, floriculture, real estate, poultry, and processed foods. The Alchemist Group represented one of Haryana and North India's prominent multi-sector business groups. Alchemist's most prominent business was Alchemist Hospitals — a chain of hospitals in Panchkula, Haryana, providing multi-specialty healthcare services. The group also operated Alchemist Infra Realty (real estate development), Alchemist F&B (fine dining and food service), Alchemist Capital (financial services), and various other verticals under the Alchemist brand. However, Alchemist Limited has faced serious financial difficulties. As of available records, the company is under CIRP (Corporate Insolvency Resolution Process) as part of proceedings under the Insolvency and Bankruptcy Code (IBC). The last balance sheet filed was as of March 2019, and the company's insolvency status means it is being administered by a Resolution Professional. The Alchemist Group's insolvency reflects the broader challenges faced by many diversified Indian conglomerates that expanded aggressively across unrelated sectors funded by debt. The healthcare, hospitality, and real estate expansion required significant capital, and when business conditions deteriorated, the debt servicing burden became unsustainable. The current CIRP status means the company's assets are being evaluated for resolution through either sale, restructuring, or liquidation under IBC proceedings.
Key Milestones
Incorporated December 5, 1988 in New Delhi (CIN: L72200DL1988PLC192643)
Common questions about unlisted shares
You buy from and sell to the wisefolio desk — shares route through the desk's demat, money-in before shares-out.
You enquire
· Takes 2 minutesTell us the company and quantity you want. Share your demat details so we can settle directly into your account.
We source & quote
· Typically within 1 business dayOur desk sources the shares and comes back with a firm price and an allocation for the quantity available.
You accept the allocation
· Quote valid for 3 daysReview the price, quantity and total. Accept to lock the allocation. The quote is valid for a short window before it needs re-pricing.
You transfer the funds
· Pay within 2 days of acceptingPay by direct bank transfer to the desk's published account — never to a personal account. We confirm receipt and begin the transfer.
Shares reach your demat
· Usually credited within 2–3 business daysOnce payment is verified, the shares are transferred from the desk's demat into yours, and you receive a transfer confirmation.
A principal desk for unlisted & pre-IPO shares — you transact with us, not a stranger.
You enquire
Takes 2 minutes
We source & quote
Typically within 1 business day
You accept the allocation
Quote valid for 3 days
You transfer the funds
Pay within 2 days of accepting
Shares reach your demat
Usually credited within 2–3 business days
Unlisted shares are illiquid and carry higher risk. Pricing is indicative, not live, and these are private off-market transactions with no exchange settlement guarantee. Read the full risk disclosure.
Be the first to discuss Alchemist — share your research, ask questions, or compare notes with other investors.
Potential asset monetization or strategic divestment of real estate or hospitality assets
Healthcare sector growth could improve hospital occupancy and revenues
Possible debt restructuring or management change to unlock value
India's hospitality recovery post-COVID could benefit hotel operations
Industry Headwinds
Deep value trap with share price at ₹1.1 suggesting structural issues
Competition from focused sector leaders in each business vertical
Continued capital drain from multiple underperforming segments
Key Strengths
Established track record of operations, regulatory approvals in place and healthy occupancy levels
Established infrastructure and wide range of services offered
Moderate financial risk profile
Growing demand in the healthcare sector
Key Weaknesses
Modest scale of operations and fluctuating profitability margins
Limited geographical reach and competition from established players in the region
Key strengths
Established track record of operations, regulatory approvals in place and healthy occupancy levels
Established infrastructure and wide range of services offered
CRITICAL: Company under CIRP (Corporate Insolvency Resolution Process) — insolvency proceedings active
Source: IBBI / MCA Public Records
Last balance sheet filed March 2019 — no recent regulatory filings
Source: Media Reports / Public Records
Original promoter management not in control — administered by Resolution Professional
Source: Media Reports / Public Records
The very low share price of ₹1.1 is a strong indicator of possible accumulated losses or significant financial stress. Investors face high risk of capital erosion.
Operating across healthcare, hospitality, and real estate simultaneously demands significant capital and management bandwidth, often leading to underperformance in each segment.
Healthcare regulations (Clinical Establishments Act), RERA for real estate, and hospitality licensing requirements create multi-dimensional compliance obligations.
Each vertical faces competition from focused, well-capitalized players: Fortis/Max in healthcare, IHCL/Marriott in hospitality, DLF/Godrej in real estate.
As an unlisted company with minimal public disclosures, Alchemist's financial condition is opaque to outside investors.
LEMONTREE · ~8000 Cr
DLF · ~180000 Cr
Built conglomerate across healthcare, pharma, food processing, real estate, tea estates
Faced debt defaults and insolvency; admitted to CIRP under IBC
Last balance sheet filed 2019; shares delisted; share price at Rs.1.1